RadNet (RDNT) Earnings Date & Reports

Key Takeaways

• RadNet reported adjusted earnings per share (EPS) of $0.30 for the third quarter of 2026, beating the consensus estimate of $0.22 by $0.08.
• Total revenue rose roughly 22% year over year to $638.26 million, slightly below the $639.67 million consensus estimate.
• On a generally accepted accounting principles (GAAP) basis, net income was $4.15 million, or $0.05 per diluted share, compared with $5.42 million, or $0.07 per share, a year earlier.
• The company's profitability beat helped support investor confidence even as the top line came in just shy of Wall Street's forecast.
• Get more details on RadNet's Major News, Today's Price Move, Price Targets, and Forecast on dedicated Tickeron pages.
• Explore Trending AI Robots to discover AI-driven trading strategies built for changing market conditions.

Earnings Context and Why It Matters

RadNet, Inc. (RDNT) is one of the largest providers of outpatient diagnostic imaging services in the United States, operating a growing network of imaging centers alongside its DeepHealth digital health and artificial intelligence (AI) business. The company's quarterly earnings are closely watched because they reflect broader trends in healthcare utilization, reimbursement, and the adoption of AI-enabled radiology tools. RadNet has been delivering strong double-digit revenue growth, driven by same-center volume gains, an increasing mix of advanced imaging procedures, and acquisitions. With the Digital Health segment expanding rapidly, investors are focused on how quickly recurring AI and informatics revenue is scaling and how effectively the company converts that growth into profitability.

Reported Results

For the third quarter of 2026, ended September 30, 2026, RadNet reported total revenue of $638.26 million, up approximately 22.1% from $522.87 million in the prior-year period. Revenue came in modestly below the consensus estimate of $639.67 million. On an adjusted (non-GAAP) basis, the company posted EPS of $0.30, exceeding the analyst consensus of $0.22 by $0.08. On a GAAP basis, net income was $4.15 million, or $0.05 per diluted share from continuing operations, compared with $5.42 million, or $0.07 per share, in the same quarter last year.

The divergence between the adjusted and GAAP figures reflects the impact of items such as acquisition-related costs and other non-cash charges, which management excludes when evaluating underlying operating performance. The bottom-line beat, paired with a top line that narrowly trailed expectations, framed a quarter in which profitability momentum outpaced revenue growth relative to Street projections.

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is built to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, supporting a more data-driven approach to research. Explore the AI Screener to see how automated signals can complement your earnings-focused analysis.

Market Reaction and Investor Sentiment

RadNet shares rose approximately 2.8% following the third-quarter report, according to earnings call coverage, as investors weighed a stronger-than-expected adjusted profit against a modest revenue shortfall. The reaction suggests the market focused more on the company's profitability beat and continued revenue expansion than on the slight top-line miss. Heading into the report, sentiment was supported by a track record of double-digit revenue growth and accelerating digital health momentum, though reimbursement policy changes remained a point of caution for the sector.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will be watching whether RadNet can sustain its strong revenue growth while converting more of that growth into adjusted profitability. Management has previously raised its full-year 2026 guidance for the Imaging Center business, targeting imaging center revenue of roughly $2.37 billion to $2.42 billion, adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $345 million to $358 million, and free cash flow of $115 million to $125 million.

The Digital Health segment remains a focal point. RadNet has highlighted rapid growth in annual recurring revenue (ARR) from its DeepHealth AI and informatics offerings, and investors will be tracking how quickly this recurring revenue scales toward management's year-end targets.

Reimbursement dynamics also warrant attention. The Centers for Medicare & Medicaid Services (CMS) released its final Medicare physician fee schedule rule in early November, which includes a reduction to the conversion factor used to calculate many Medicare payments. While the exact impact on RadNet's business will depend on its payer mix and procedure mix, reimbursement changes are a key variable for the imaging industry broadly.

Finally, acquisition integration, same-center volume trends, and the pace of AI adoption across RadNet's imaging centers will be important signals for both revenue growth and long-term margin expansion.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations